FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Breakthrough for Limaca Endoscopic Ultrasound Biopsy

FDA grants Limaca Medical a breakthrough device designation for its Precision-GI endoscopic ultrasound biopsy product.

Medical Devices

3 ICSR Electronic Transmission Guidances

FDA publishes 3 guidances on implementing an International Council on Harmonization guidance on electronic submission of individual case safety report...

Medical Devices

Lasik Injury Advocate Urges Action on Misleading Ads

Vision Advocacy president Paula Cofer writes FDA commissioner Robert Califf urging regulatory action against refractive eye surgery providers who have...

Biologics

Covid-19 and Annual Vaccinations is the New Normal: FDA

Writing in a 5/2 online JAMA viewpoint, senior FDA officials prepare the agency and the public to accept that Covid-19 infections and upcoming seasona...

Federal Register

Advisory Panel to Vote on Nuplazid Resubmission

Federal Register notice: FDA announces a 6/17 Psychopharmacologic Drugs Advisory Committee meeting to vote on an Acadia Pharmaceuticals resubmitted su...

Human Drugs

CGMP Deviations at Miami University Contract Lab

FDA warns the Oxford, OH-based Miami University Department of Chemistry and Biochemistry contract testing laboratory about CGMP deviations in its test...

Federal Register

Info Collection on Device Administrative Detention

Federal Register notice: FDA sends to OMB an information collection extension entitled Administrative Detention and Banned Medical Devices.

Human Drugs

FDA Rejects HutchMed NDA Over China Trial Data

FDA sends HutchMed a complete response letter on its NDA for surufatinib, indicated for treating pancreatic and extra-pancreatic neuroendocrine tumors...

Human Drugs

No FDA Action Against Accused Researchers

FDA denies a Public Citizen petition calling for the disqualification of two researchers at Hennepin County Medical Center, Minneapolis, MN, who repea...

Federal Register

Regeneron Awarded Priority Review Voucher

Federal Register notice: FDA issues Regeneron Pharmaceuticals a priority review voucher under its material threat medical countermeasure product progr...